Inventor · disambiguated record
Yoshiyuki Okumura
Also filed as: OKUMURA YOSHIYUKI
18 granted patents·7 pending applications·273 citations·filing 1991–2024
94Inventor score
Top patents by PatentIndex Score
25 records- 0191US5883106A5-lipoxygenase inhibitorsPFIZER·Filed 1998·Granted Mar 16, 1999·58 cites·13 claims
- 0290US7534914B2Substituted methyl aryl or heteroaryl amide compoundsREQUALIA PHARMA INC·Filed 2005·Granted May 19, 2009·36 cites·12 claims
- 0390US7479564B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsRAQUALIA PHARMA INC·Filed 2006·Granted Jan 20, 2009·21 cites·13 claims
- 0488US6710054B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2001·Granted Mar 23, 2004·35 cites·16 claims
- 0587US8084476B2Substituted methyl aryl or heteroaryl amide compoundsKOIKE HIROKI·Filed 2009·Granted Dec 27, 2011·12 cites·12 claims
- 0683US9447066B2Salts and crystal formsASKAT INC·Filed 2014·Granted Sep 20, 2016·8 cites·11 claims
- 0783US7238714B2Aryl or heteroaryl amide compoundsPFIZER JAPAN INC·Filed 2004·Granted Jul 3, 2007·30 cites·27 claims
- 0883US7141580B2Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agentsPFIZER·Filed 2004·Granted Nov 28, 2006·19 cites·12 claims
- 0972US6310079B1Benzimidazole cyclooxygenase-2 inhibitorsPFIZER·Filed 1999·Granted Oct 30, 2001·26 cites·11 claims
- 1069US6444677B25-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonistsPFIZER·Filed 2000·Granted Sep 3, 2002·6 cites·9 claims
- 1168US2024254120A1Ep4 inhibitors and synthesis thereofARRYS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1266US2024352004A1Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-olASKAT INC·Filed 2024·Application pending·0 cites
- 1365US11964963B2Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-olASKAT INC·Filed 2021·Granted Apr 23, 2024·0 cites·26 claims
- 1458US6063928A5-lipoxygenase inhibitorsPFIZER·Filed 1998·Granted May 16, 2000·7 cites·4 claims
- 1556US2021300921A1Ep4 inhibitors and synthesis thereofARRYS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1655US2004181062A1Benzimidazole cyclooxygenase-2 inhibitorPFIZER·Filed 2004·Application pending·0 cites
- 1754US9447065B2Pharmaceutical compositionRAQUALIA PHARMA INC·Filed 2012·Granted Sep 20, 2016·0 cites·18 claims
- 1850US6713482B2Benzimidazole cyclooxygenase-2 inhibitorsPFIZER·Filed 2001·Granted Mar 30, 2004·0 cites·10 claims
- 1950US5521212ACyclopropyl N-hydroxyurea and N-hydroxyacetamides which inhibit lipoxygenasePFIZER·Filed 1992·Granted May 28, 1996·3 cites·11 claims
- 2047US5681858ACycloalkyl hydroxyureasPFIZER·Filed 1994·Granted Oct 28, 1997·6 cites·13 claims
- 2146US6291520B1Hydroxamic acid and N-hydroxyurea derivatives and their usePFIZER·Filed 1991·Granted Sep 18, 2001·6 cites·29 claims
- 2245US2003176445A1Substituted 1,4-dihydropyridine compounds as bradykinin antagonistsPFIZER·Filed 2003·Application pending·0 cites
- 2341US2005250818A1Ortho substituted aryl or heteroaryl amide compoundsPFIZER·Filed 2005·Application pending·0 cites
- 2441US2002042421A1Substituted 1,4-dihydropyridine compounds as bradykinin antagonistsFiled 2001·Application pending·0 cites
- 2540US11555023B2Process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acidsASKAT INC·Filed 2020·Granted Jan 17, 2023·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →